Wolverine Asset Management’s Achillion Pharmaceuticals ACHN Stock Holding History

Wolverine Asset Management’s Portfolio ACHN Stock Details ACHN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q3	–	Sell	-38	Closed	-$17K	–	2765
2014 Q2	$17K	Sell	38 -6	-14%	-$24	﹤0.01%	1734
2014 Q1	$4K	Buy	44 +6	+16%	+$21	﹤0.01%	2038
2013 Q4	$1K	Buy	+38	New	+$110	﹤0.01%	2626
2013 Q3	–	Sell	-61	Closed	-$2K	–	2935
2013 Q2	$2K	Buy	+61	New	+$466	﹤0.01%	2520

Wolverine Asset Management's ACHN Position: Q1 2020 in Review

Wolverine Asset Management sold out of Achillion Pharmaceuticals (ACHN) in Q1 2020, closing a stake of 63,091 shares — an estimated $380K sold.

Wolverine Asset Management first reported a position in ACHN in Q2 2013 and held it in 8 quarters. The position peaked at $380K in Q4 2019. 0 funds tracked by Wall St. Rank hold ACHN as of Q1 2020.

Wolverine Asset Management reported no remaining Achillion Pharmaceuticals position as of Q1 2020 after selling out during the quarter.
Wolverine Asset Management sold 63,091 Achillion Pharmaceuticals shares in Q1 2020, an estimated $380K.
Wolverine Asset Management first reported a position in Achillion Pharmaceuticals in Q2 2013 and held it in 8 quarters.
Wolverine Asset Management's Achillion Pharmaceuticals position peaked at $380K in Q4 2019.
0 funds tracked by Wall St. Rank held Achillion Pharmaceuticals as of Q1 2020.

Based on Wolverine Asset Management's 13F filing for Q1 2020, filed 13 May 2020.